Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

ulcers, infections, feeling weak or tired, cough and diarrhea. Common side effects of Afinitor in patients with SEGA include mouth ulcers, infections of the respiratory tract, sinuses and ears and fever.

Please see full Prescribing Information for Afinitor.

DisclaimerThe foregoing release contains forward-looking statements that can be identified by terminology such as "is being presented," "may," "can," "will," "potential," "ongoing," or similar expressions, or by express or implied discussions regarding potential new indications or labeling for everolimus or regarding potential future revenues from everolimus. You should not place undue reliance on these statements. Such forward-looking statements reflect the current views of management regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with everolimus to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that everolimus will be submitted or approved for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that everolimus will achieve any particular levels of revenue in the future. In particular, management's expectations regarding everolimus could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; government, industry and general public pricing pressures; competition in general; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and facto
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... and ASPEN, Colo. , April ... with the Chris Klug Foundation (CKF), is pleased to sponsor ... being accepted for the award, which will recognize two ... life, whether it is a career accomplishment, participation in ... life with family and loved ones. ...
(Date:4/1/2015)... , April 1, 2015 According ... (Neuro & Spine Surgery, Plastic and Reconstructive Surgery, Oncology, ... (Hospitals, Outpatient Facilities) - Global Forecast to 2020", published ... reach $806.6 Million by 2020 from $402.2 Million in ... 2020.. Browse   7 6 ...
(Date:4/1/2015)... INDIANAPOLIS , April 1, 2015 Eli Lilly ... results for the first quarter of 2015 on Thursday, April ... that day with the investment community and media to further ... will begin at 9:00 a.m. EDT. Investors, media, and the ... call through a link that will be posted on Lilly,s ...
Breaking Medicine Technology:Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3Surgical Microscopes Market Worth $806.6 Million by 2020 2Surgical Microscopes Market Worth $806.6 Million by 2020 3Surgical Microscopes Market Worth $806.6 Million by 2020 4Lilly Confirms Date and Conference Call for First-Quarter 2015 Financial Results Announcement 2
... the launch of its new depot service for Agilent ... to BioSurplus for repair and preventative maintenance by trained ... major cost savings to customers outside of biotech hubs ... An introductory 15% discount on preventative maintenance services ...
... 8, 2012  Insmed Incorporated (Nasdaq: INSM ), a ... March 31, 2012. Key Recent Highlights: ... hold on ARIKACE® (liposomal amikacin for inhalation) in Cystic Fibrosis ... Initiated dosing in CL inical E valuation of ...
Cached Medicine Technology:BioSurplus Announces Launch of Depot Service for Agilent and AKTA HPLCs 2Insmed Announces First Quarter 2012 Financial Results 2Insmed Announces First Quarter 2012 Financial Results 3Insmed Announces First Quarter 2012 Financial Results 4Insmed Announces First Quarter 2012 Financial Results 5Insmed Announces First Quarter 2012 Financial Results 6Insmed Announces First Quarter 2012 Financial Results 7
(Date:4/1/2015)... April 01, 2015 The Pennsylvania Court ... lawsuits ( http://www.risperdallawsuit2014.com/ ) has scheduled a meeting ... the Philadelphia Court of Common Pleas, the meeting will ... Hall. Court records indicate that the proceeding will address ... of Risperdal users who experienced gynecomastia (male breast growth) ...
(Date:4/1/2015)... Eagan, Minn. (PRWEB) April 01, 2015 ... Shield of Minnesota and its family of companies (Blue ... Cross closed out the year with net income of ... slight operational losses. The organization reported a net operating ... billion, for a negative operating margin of one-tenth of ...
(Date:4/1/2015)... 2015 Parents of teenaged and adolescent ... where the latest post discusses Teen Violence Related to ... Teen Dating Violence Awareness Month, the substance abuse treatment ... to help parents identify if there may be problems ... involve drugs or alcohol. , “People learn how to ...
(Date:4/1/2015)... 01, 2015 South Florida’s newest concept ... of Authority (PCOA) approval from the State of Florida. ... ongoing development of a retirement community that will offer ... and spiritual development. , America’s aging population is experiencing ... housing needs of seniors, according to a recent report ...
(Date:4/1/2015)... April 01, 2015 eMindful , ... expansion of its executive team with the addition of ... officer. , In his new role, Suissa ... user interface across the business and consumer portals. He ... building the company’s online community. His hiring was ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 2Health News:Blue Cross and Blue Shield of Minnesota Reports 2014 Results 3Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3
... were cut by half to an average national rate of ... cases of lung cancer by 2030 and save $656 million ... platform developed for the Canadian Partnership Against Cancer and presented ... hosted by the International Association for the Study of Lung ...
... diseases (NCD), such as cardiovascular disease, diabetes, arthritis, chronic ... problem of the 21st century and affect all age ... and for many countries is an under-appreciated cause of ... Genome Medicine an international group of scientists ...
... 5 (HealthDay News) -- Healthy living significantly reduces a woman,s ... Researchers analyzed data from about 82,000 women who participated ... those 26 years, there were 321 cases of sudden cardiac ... died was 72. Four low-risk lifestyle factors were significantly ...
... HealthDay Reporter , TUESDAY, July 5 (HealthDay News) ... for easing low back pain in the short term, a ... mostly middle-aged, female and white, all of whom had chronic ... of either relaxation massage or structural massage were better able ...
... reduce colorectal cancer risk, according to a new study ... American Gastroenterological Association (AGA) Institute. Folate is a water-soluble ... found that all forms and sources of folate were ... Stevens, PhD, of the American Cancer Society and lead ...
... HealthDay Reporter , MONDAY, July 4 (HealthDay News) ... heart attacks and strokes by as much as 72 percent ... researchers say. The new study comes just over a ... small but significant risk of heart attack and stroke among ...
Cached Medicine News:Health News:Canada's Cancer Risk Management model is an important new health tool for policymakers 2Health News:Massage Beats Meds for Lower Back Pain, Study Says 2Health News:High folate intake may reduce risk of colorectal cancer 2Health News:Stop-Smoking Drug Chantix Ups Risk of Heart Problems: Study 2Health News:Stop-Smoking Drug Chantix Ups Risk of Heart Problems: Study 3Health News:Stop-Smoking Drug Chantix Ups Risk of Heart Problems: Study 4
The major innovation in posterior stabilized (PS) knee design. Improve patellofemoral kinematics. Reduce wear rate potential. Increase resistance to posterior tibial dislocation. Achieve at least 120...
... knee replacement is an exciting development in ... provides patients with a minimally invasive solution ... knee often results in severe pain, loss ... and even depression. Orthopedic surgeons have worked ...
... tricompartmental total knee prosthesis stems from many ... design and manufacturing technologies have been used ... as well as a favorable pressure distribution ... keep wear to a minimum. The inherent ...
Cemented hip system...
Medicine Products: